medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2011, Number 96

<< Back Next >>

Rev Enfer Infec Pediatr 2011; 24.25 (96)

Diagnosis of scarlet fever in 151 cases in the pediatric emergency department during 2006-2008

Ortigosa GS, Sánchez BA, Crehuet AM, Martínez-Roig A

Language: Spanish
References: 22
Page: 154-161
PDF size: 204.01 Kb.


ABSTRACT

Background: Scarlet fever is a disease that still exist. Since it is basically clinically diagnosed, there will always be some doubt about its correct diagnosis and when to practice complementary explorations.
Objective: To know the current reality of scarlet fever cases.
Materials and Methods: Retrospective study of children diagnosed of scarlet fever. Cases discharged with diagnosis of scarlet fever by the pediatric emergency department from a general hospital of Barcelona, Spain, were collected between 2006-2008.
Results:151 cases were diagnosed. 47 aged under 3 years. Characteristic exanthema was described in 142 cases. Tonsillitis existed in 134 cases, red strawberry tongue in 26 and white in 11. Some accompanying symptoms were: odynophagia, vomiting or pruritus. Diagnosis was confirmed by pharyngeal frotis in 118 cases. The majority was treated with amoxicillin and penicillin and just 6 with a different antibiotic.
Conclusion: Of particular note were: detection in subjects under 3 years of age, variety in exanthema, predominant prescription of amoxicillin and penicillin and lower number of cases in summer.


REFERENCES

  1. Salazar V, Escr bano R. Infecciones estreptocócicas. Escarlatina. En: Cruz Hernandez M. Tratado de Pediatría. 9ª ed. Madrid: Ergon, 2006;494-495.

  2. Darmstadt GL, Galen WK, Fischer G. Bacterial infections. In: Schachner LA, Hansen RC. Pediatric Dermatology. 3rd ed. Edimburgh: Mosby, 2003;989-1057.

  3. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998;39:383-398.

  4. Davies RJ, de Bono JP. A young rash on old shoulders-scarlet fever in an adult male. Lancet Infect Dis 2002;2:750.

  5. Hall-Baker PA, Nieves E, Jajosky RA, Adams DA, et al. Summary of notifiable diseases--United States 2007. MMWR Morb Mortal Wkly Rep 2009;56:1-98.

  6. Sevilla Ramos P, Martino A ba R, Carrasco Torres A, Alonso Cristobo M, y col. Escarlatina: una enfermedad actual (revisión de 165 casos). Acta Pediatr Esp 2003;61:292-295.

  7. Canals M. Dinámica epidemiológica de la escarlatina en Chile. Rev Chil Pediatr 1989;60:15-18.

  8. Ronveaux O, Bosman A, Reintjes R, Conyn-van Spaendonck M. Epidemiología descriptiva de los exantemas en la región de Rotterdam, enero de 1997 a junio de 1998. Eurosurveillance 1998;3:122- 124.

  9. Lamagni TL, Efstatriou A, Dennis A, Nair P, Keamey J, George R, and behalf on the national incident management team. Increase in invasive group S streptococcal infections in England, Wales and Northern Ireland. Eurosurveillance 2009;14:1-2.

  10. Martínez A, Madrin M, Negredo T, Larumbe Y, Sánchez de Dios M. Brote de escarlatina en un centro de salud urbano en 1997. An Esp Pediatr 1998;48:103-104.

  11. Test Pack-About Strep A [homepage] (2009). En: http://www. testpack.com/index/strep_a/about_strep_a.aspx. Acceso: 08 de Septiembre 2010.

  12. Mellick LB. Group A Streptococcal Infection Observations. Pediatr Emerg Care 2009;25:621-623.

  13. Casani C, Morales M, Santos M, Otero MC, Pérez D Asensi F. Escarlatina recurrente. An Esp Pediatr 1999;51:300-302.

  14. Long SH. Mucocutaneous Symptom complexes. Long SS, Pickering LK, er Ch G. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia: Elsevier, 2008;118-123.

  15. Dyne PL. Pediatrics, Scarlet Fever. In: Overview-eMedicine Emergency [homepage] (1994-2009). En: http://www.emedicine. com/emerg/topic402.htm#section~medication. Acceso: 08 de septiembre 2010.

  16. Baselga E, Drolet BA, Esterly NB. Purpura in infants and children. J Am Acad Dermatol 1997;37:673-705.

  17. Baltimore RS. Re-evaluation of antibiotic treatment of streptococcal pharyngitis. Curr Opin Pediatr 2010;22:77-82.

  18. Brook I, Gober AE. Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir. Int J Pediatr Otorhinolaryngol 2009;73:757-759.

  19. Gené A, Ardanuy C, Palacín E, García-García JJ. Aumento de la resistencia a macrólidos mediada por metilasas en Streptococcus pyogenes en un hospital pediátrico de Barcelona. Enferm Infecc Microbiol Clin 2006;24:26-28.

  20. Michos AG, Bakoula CG, Braoudaki M, Koutouzi FI, et al. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn Microbiol Infect Dis 2009;64:295-299.

  21. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119:1541-1551.

  22. Puerto Alonso JL, García-Martos P, Girón González JA. Infecciones por Arcanobacterium haemolyticum: un patógeno emergente. An Med Interna 2001;19:473-476.




2020     |     www.medigraphic.com